TAMI SANTO: Open Payments
NPI 1801224688 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,317 in 91 payments from 17 companies in 2025. Trend: 2023 $3,199 · 2024 $2,838 · 2025 $2,317
Food & beverage: $2,234Education: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $481 |
| Janssen Biotech, Inc. | 7 | $227 |
| Novartis Pharmaceuticals Corporation | 8 | $215 |
| LNHC, Inc | 5 | $212 |
| Regeneron Healthcare Solutions, Inc. | 6 | $208 |
| UCB, Inc. | 4 | $202 |
| Botanix SB Inc | 10 | $154 |
| PFIZER INC. | 11 | $150 |
| Lilly USA, LLC | 4 | $101 |
| GENZYME CORPORATION | 3 | $100 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, ZELSUVMI, Bimzelx, SOFDRA, CIBINQO, EBGLYSS.
Industry payments across FL — which companies pay providers there.
